Teradyne
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Teradyne is a two-sided play on the robot boom: it owns half of the semiconductor automated-test-equipment duopoly that every AI and robot chip must pass through, and it owns Universal Robots and MiR, the market-leading collaborative-robot and autonomous-mobile-robot franchises.
Teradyne's moat is strongest exactly where the robot boom is most capital-intensive — at the test gate for silicon and at the cobot standard on the factory floor:
- The ATE Duopoly: In system-on-chip automated test equipment, Teradyne and Advantest form an effective duopoly. A chipmaker develops its test program against a specific Teradyne platform (UltraFLEX/UltraFLEXplus), correlates yield data to it, and qualifies it into high-volume production. Re-porting that test program and re-correlating to a competitor's tester is expensive and risky, so incumbency at a given customer is durable across product generations — and AI accelerators and robot SoCs are among the most test-intensive silicon ever built.
- Universal Robots — the Cobot Standard: Universal Robots defined the collaborative-robot category and remains its share leader, with the UR+ ecosystem of certified grippers, vision systems, and application kits acting as a genuine platform network effect. Integrators and end-users trained on UR's interface, and the library of deployed applications, make UR the default cobot spec — the same install-base dynamic that protects the industrial-automation incumbents, at the human-scale end of the market.
- Wafer-to-AI-Datacenter Positioning: With roughly 70% of revenue tied to AI-related demand, Teradyne sells into the entire arc from wafer test through to the robots that build and move physical goods. Q1 2026 revenue rose 87% YoY on AI and data-center test demand, while the robotics segment posted its fourth consecutive quarter of growth. Teradyne monetises the boom whether the winning chip is NVIDIA's or a custom accelerator, and whether the robot is a cobot or a humanoid — a picks-and-shovels breadth that individual robot bets lack.
Moat Verdict
Teradyne is a net beneficiary of both AI and the robot boom — its ATE duopoly is the test gate for the most test-intensive silicon ever built, and Universal Robots is the cobot standard, both of which AI adoption accelerates rather than threatens. The genuine risks are cyclical rather than structural: semiconductor test demand swings with capex, robotics is still sub-scale, and a ~66× multiple leaves little room for disappointment.
51.5 resilient · 65.0 vulnerable · 80/20 = 54.2 · = 54
Open a moat to read its note.
Test engineers develop and maintain device test programs on Teradyne's platform-specific software, and UR's programming interface is the one cobot integrators are trained on — real but not insurmountable switching costs on both sides of the business.
A production test program is customised and yield-correlated to one tester platform over months of qualification, so re-porting it to a rival tester is costly and incumbency carries across chip generations. Advantest holds the same lock on its own installed base, and no share or retention figure is on file to show Teradyne's is exceptional, so it rates intact.
Teradyne is a test-equipment and robotics hardware business with no reliance on public data aggregation as a moat source.
Test-engineering and precision-robotics talent is scarce, and the expertise concentrated around Teradyne's platforms reinforces customer incumbency more than it protects Teradyne exclusively.
Teradyne cross-sells its semiconductor test, product test, and robotics portfolios, and the UR+ ecosystem bundles certified accessories and applications around the core cobot — increasing stickiness without being a hard bundle.
Decades of device-test and yield-correlation data across the installed base inform test-program development and hardware roadmaps, a data advantage that compounds with the qualified base.
No external regulatory certification protects Teradyne. Chips and lines qualified to specific testers are customer-driven switching cost, which belongs under transactionEmbedding, not a regulatory barrier. Previously weakened.
The UR+ platform of certified grippers, vision, and application kits, plus the integrator community trained on Universal Robots, creates a genuine two-sided platform effect around the cobot standard — the strongest network dynamic in the portfolio of businesses.
Service contracts, spares, and software attach provide recurring revenue on the installed base, but the model remains capital-equipment sales rather than per-transaction embedding.
Test programs, correlation data, and robot application configurations reside on Teradyne platforms and carry institutional inertia, but Teradyne is not the authoritative system of record for a customer's core business function.
Fabless or equipment franchise whose edge is IP and process know-how, rated elsewhere; manufacturing volume does not give it a unit-cost lead rivals cannot buy.
Buyers are enterprises choosing on switching cost, integration and performance, which the other pillars rate. The name carries reputation, not a price premium it could hold on brand alone.
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
Teradyne is a two-sided play on the robot boom: it owns half of the semiconductor automated-test-equipment duopoly that every AI and robot chip must pass through, and it owns Universal Robots and MiR, the market-leading collaborative-robot and autonomous-mobile-robot franchises.
Growth Score
Q2 2026 revenue was a record $1.329B (+104% YoY, above the top of the $1.15–1.25B guide), after $1.28B (+87%) in Q1. Semiconductor test was $1.122B (+128% YoY), with compute test up nearly 600% on AI accelerators and record memory test on DRAM and a NAND final-test resurgence; product test was $107M (+26%) and robotics $100M (+33%, about the same pace as Q1's $91M against $69M). AI-related demand was more than 60% of sales. Non-GAAP gross margin was 59.8%, down from 60.9% in Q1 but up 250bp YoY, and Q3 is guided to $1.20–1.30B revenue at a 58–59% gross margin on new-product mix. The growth is powerful but genuinely cyclical — ATE demand swings with the semiconductor capex cycle — so the trajectory is high but the amplitude and the rich starting multiple both matter to forward returns.
Valuation Score
At ~$389 (September 23, 2026 close, $389.14) Teradyne sits ~11% above the reset base ($350) and ~23% of the way to the $520 bull, ~66% above the $235 bear — piecewise 60. The July ladder put the base at $380, above the then-$359 price, which scored the stock as cheap while this description called it demanding; the ladder is now anchored on Street 2027 EPS so the two agree. At ~$61B market cap (~157M diluted shares) TER trades at ~51× trailing non-GAAP EPS ($7.68 across Q3'25–Q2'26) and ~33× the ~$11.64 2027 consensus. Base is 30× that consensus, bear 25× the low 2027 estimate ($9.33), bull 38× the high ($13.66). Q2 revenue was $1.329B (+104%) with non-GAAP EPS $2.47, but the Q3 guide ($1.20–$1.30B, non-GAAP EPS $1.85–$2.15) steps down sequentially — the multiple is paying for 2027 rather than the next print. This is a high-quality name at a demanding price, better accumulated on cyclical weakness than chased after the AI-test re-rating.
The Gatekeeper and the Cobot Leader
Teradyne's moat is strongest exactly where the robot boom is most capital-intensive — at the test gate for silicon and at the cobot standard on the factory floor:
- The ATE Duopoly: In system-on-chip automated test equipment, Teradyne and Advantest form an effective duopoly. A chipmaker develops its test program against a specific Teradyne platform (UltraFLEX/UltraFLEXplus), correlates yield data to it, and qualifies it into high-volume production. Re-porting that test program and re-correlating to a competitor's tester is expensive and risky, so incumbency at a given customer is durable across product generations — and AI accelerators and robot SoCs are among the most test-intensive silicon ever built.
- Universal Robots — the Cobot Standard: Universal Robots defined the collaborative-robot category and remains its share leader, with the UR+ ecosystem of certified grippers, vision systems, and application kits acting as a genuine platform network effect. Integrators and end-users trained on UR's interface, and the library of deployed applications, make UR the default cobot spec — the same install-base dynamic that protects the industrial-automation incumbents, at the human-scale end of the market.
- Wafer-to-AI-Datacenter Positioning: With roughly 70% of revenue tied to AI-related demand, Teradyne sells into the entire arc from wafer test through to the robots that build and move physical goods. Q1 2026 revenue rose 87% YoY on AI and data-center test demand, while the robotics segment posted its fourth consecutive quarter of growth. Teradyne monetises the boom whether the winning chip is NVIDIA's or a custom accelerator, and whether the robot is a cobot or a humanoid — a picks-and-shovels breadth that individual robot bets lack.
Moat Verdict
Teradyne is a net beneficiary of both AI and the robot boom — its ATE duopoly is the test gate for the most test-intensive silicon ever built, and Universal Robots is the cobot standard, both of which AI adoption accelerates rather than threatens. The genuine risks are cyclical rather than structural: semiconductor test demand swings with capex, robotics is still sub-scale, and a ~66× multiple leaves little room for disappointment.
51.5 resilient · 65.0 vulnerable · 80/20 = 54.2 · = 54
Open a moat to read its note.
Test engineers develop and maintain device test programs on Teradyne's platform-specific software, and UR's programming interface is the one cobot integrators are trained on — real but not insurmountable switching costs on both sides of the business.
A production test program is customised and yield-correlated to one tester platform over months of qualification, so re-porting it to a rival tester is costly and incumbency carries across chip generations. Advantest holds the same lock on its own installed base, and no share or retention figure is on file to show Teradyne's is exceptional, so it rates intact.
Teradyne is a test-equipment and robotics hardware business with no reliance on public data aggregation as a moat source.
Test-engineering and precision-robotics talent is scarce, and the expertise concentrated around Teradyne's platforms reinforces customer incumbency more than it protects Teradyne exclusively.
Teradyne cross-sells its semiconductor test, product test, and robotics portfolios, and the UR+ ecosystem bundles certified accessories and applications around the core cobot — increasing stickiness without being a hard bundle.
Decades of device-test and yield-correlation data across the installed base inform test-program development and hardware roadmaps, a data advantage that compounds with the qualified base.
No external regulatory certification protects Teradyne. Chips and lines qualified to specific testers are customer-driven switching cost, which belongs under transactionEmbedding, not a regulatory barrier. Previously weakened.
The UR+ platform of certified grippers, vision, and application kits, plus the integrator community trained on Universal Robots, creates a genuine two-sided platform effect around the cobot standard — the strongest network dynamic in the portfolio of businesses.
Service contracts, spares, and software attach provide recurring revenue on the installed base, but the model remains capital-equipment sales rather than per-transaction embedding.
Test programs, correlation data, and robot application configurations reside on Teradyne platforms and carry institutional inertia, but Teradyne is not the authoritative system of record for a customer's core business function.
Fabless or equipment franchise whose edge is IP and process know-how, rated elsewhere; manufacturing volume does not give it a unit-cost lead rivals cannot buy.
Buyers are enterprises choosing on switching cost, integration and performance, which the other pillars rate. The name carries reputation, not a price premium it could hold on brand alone.
Growth Analysis
Growth Drivers
Key Risk
A semiconductor capex down-cycle cuts ATE orders sharply while the still-small robotics segment cannot offset it, and a ~66× multiple de-rates hard on any growth disappointment.
Score Derivation
80.0 base + 1.3 trajectory − 10 risk = 71
Base 80 (12-18% CAGR, midpoint 15%, measured from the peak-cycle 2026 base) + 1.3 trajectory (semiconductor test accelerating to +128% YoY in Q2 as company growth went from +87% to +104%; robotics steady at ~+33% in both quarters and product test +26% are stable: (1 − 0) / 3 × 4) + 0 margin (stable: non-GAAP gross margin 60.9% in Q1 → 59.8% in Q2, still +250bp YoY, with Q3 guided 58–59% on mix — neither expanding nor a structural compression) − 10 high risk (a semiconductor capex down-cycle cutting ATE orders, graded with KEYS and AMKR in the test-and-packaging cohort). Robotics moves from accelerating to stable on the Q2 print. The FY2026 Outlook line, held stable earlier today as a guidance roll-up, is replaced by the product test revenue line it was rolling up; the effect on trajectory is the same = 71
Price Scenarios (12–24 Months)
Where We Are vs Targets
Loading live price…
The semiconductor test cycle rolls over as AI-accelerator test intensity is pulled forward, 2027 EPS lands at the low end of the Street range, and the multiple compresses to ~25× — still above a classic semi-cap trough multiple.
- AI-accelerator and datacenter test demand normalises after a pull-forward; the Q3 2026 sequential step-down ($1.20–$1.30B guide vs $1.329B in Q2) proves the start of an air pocket rather than a pause
- Advantest presses share in high-performance SoC test, capping Teradyne's pricing and unit gains through the down-cycle
- Robotics (~$100M a quarter in Q2) remains too small to offset semiconductor-test cyclicality when it matters most
- 25× the ~$9.33 low 2027 EPS estimate → ~$235/share (~40% below $389)
AI-test demand stays structurally elevated, Teradyne holds its ATE duopoly position, 2027 EPS lands at the ~$11.64 consensus, and the market pays ~30× — in line with the KEYS test peer's high-20s/low-30s multiple — rather than re-rating further.
- AI accelerators, HBM, and custom silicon keep test intensity structurally higher; ~70% of Q1 2026 revenue was AI-linked
- Semiconductor Test ($1.122B in Q2) holds a durable step-up in baseline ATE demand through 2027
- Universal Robots and MiR sustain growth as cobots and mobile robots scale on factory and logistics floors
- 30× ~$11.64 2027 consensus EPS → ~$350/share
A physical-AI supercycle drives both sides of the business at once — humanoid and mobile-robot SoCs become a major new test-intensive category, 2027 EPS reaches the top of the Street range, and Teradyne holds a premium ~38× multiple.
- Humanoid and edge-robot silicon becomes a large new ATE end-market, extending the test-intensity tailwind well beyond datacenter accelerators
- Universal Robots and MiR inflect from ramp to scale as labor shortages and reshoring pull cobot and AMR adoption into a mass-deployment phase
- Teradyne is recognised as the diversified wafer-to-robot toll-taker on physical AI and holds a premium multiple on a much larger earnings base
- 38× the ~$13.66 high 2027 EPS estimate → ~$520/share